Sharda Cropchem Limited: Cultivating Growth and Strong Returns in Q3 & 9M FY26

Sharda Cropchem Limited, a prominent player in the global crop protection chemicals industry, has delivered a robust financial performance for the third quarter and nine months ended December 31, 2025. The company's results underscore its strategic prowess, driven by an asset-light business model, extensive product registrations, and a diversified global presence. With significant growth across key financial metrics and a confident outlook from management, Sharda Cropchem appears to be cultivating a strong path forward.

For Q3 FY26, Sharda Cropchem reported a commendable 39% year-on-year increase in revenue, reaching INR 1,288.8 crores. This growth was primarily propelled by strong volume expansion and a favorable product mix. Gross Profit surged by 48% to INR 450.3 crores, with Gross Profit Margins expanding by 220 basis points to 34.9%. The company's EBITDA grew by an impressive 59% to INR 245.5 crores, achieving an EBITDA margin of 19.1%. Notably, Profit After Tax (PAT) witnessed a phenomenal 366% growth, reaching INR 145.1 crores, translating to an EPS of INR 16.09.

The nine-month period (9M FY26) further solidified this strong trajectory, with revenues growing 29% to INR 3,202.7 crores. EBITDA for 9M FY26 increased by 64% to INR 526.7 crores, with EBITDA margins at 16.4%. The company achieved its highest-ever annual PAT within these nine months, recording INR 362.3 crores, a 259% increase over the previous year, and an EPS of INR 40.15. This exceptional performance led the Board of Directors to declare an interim dividend of INR 6 per share.

Segmental and Product Performance

The Agrochemical segment remained the primary growth engine, contributing 89% of the total revenue in Q3 FY26 and growing by 48% year-on-year to INR 1,141 crores. For 9M FY26, this segment grew by 34% to INR 2,790 crores. The Non-Agrochemical segment, while smaller, contributed 11% to Q3 revenues, with a slight degrowth of 8% to INR 148 crores, but showed a 1% growth for 9M FY26, reaching INR 413 crores.

Within the Agrochemical portfolio, all product categories demonstrated robust growth in Q3 FY26:

Regionally, Europe emerged as a standout performer in the Agrochemical business, witnessing a remarkable 123% year-on-year growth in Q3 FY26, with revenues reaching INR 654 crores. For 9M FY26, Europe's Agrochemical revenue grew by 54% to INR 1,640 crores. LATAM also showed strong growth, increasing by 68% in Q3 FY26 and 37% in 9M FY26. The NAFTA region, however, experienced a 7% degrowth in Q3 FY26 for the Agrochemical segment, attributed by management to unpredictable climate conditions.

Strategic Pillars and Future Outlook

Sharda Cropchem's success is deeply rooted in its strategic pillars. The company operates on an asset-light business model, focusing on Intellectual Property (IP) and product registrations while outsourcing manufacturing. This approach allows for scalable growth with limited capital expenditure. As of December 31, 2025, the company boasts 3,004 product registrations and has 1,076 applications pending globally, which are crucial for expanding its market reach, especially in advanced markets like Europe, North America, and Latin America.

Management emphasized its commitment to several key initiatives:

• Forward Integration and Sales Force Expansion: Leveraging market presence to adopt a factory-to-farmer approach and strengthen its sales force across key regions.
• Distribution Network Enhancement: Expanding geographical reach using existing dossiers and a two-fold strategy to penetrate existing markets deeper and enter new ones.
• Continual Investment in Registrations: Focusing on identifying generic molecules going off patent and investing in new registrations to sustain its competitive edge.
• Operational Efficiencies: Accelerating focus on revenue-generating investments, margin improvements, and better cost management.

Mr. Ramprakash Bubna, Chairman and MD, commented on the results, stating,